Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Drug and Chemical Toxicology
|
December 29, 2007
Oxime silanes: structure/toxicity relationships
Michael J Derelanko, George M Rusch
Drug and Chemical Toxicology
|
September 5, 2003
Developmental toxicity studies of methyl ethyl ketoxime (MEKO) in rats and rabbits
Michael J Derelanko, William E Rinehart, Dean E Rodwell
Inhalation Toxicology
|
November 28, 2002
An evaluation of changes and recovery in the olfactory epithelium in mice after inhalation exposure to methylethylketoxime
Paul E Newton, Henry F Bolte, Michael J Derelanko, et al.
Journal of Medicinal Chemistry
|
September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)
Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry
|
August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)
Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Drug and Chemical Toxicology
|
December 29, 2007
Oxime silanes: structure/toxicity relationships
Michael J Derelanko, George M Rusch
Drug and Chemical Toxicology
|
September 5, 2003
Developmental toxicity studies of methyl ethyl ketoxime (MEKO) in rats and rabbits
Michael J Derelanko, William E Rinehart, Dean E Rodwell
Inhalation Toxicology
|
November 28, 2002
An evaluation of changes and recovery in the olfactory epithelium in mice after inhalation exposure to methylethylketoxime
Paul E Newton, Henry F Bolte, Michael J Derelanko, et al.
Journal of Medicinal Chemistry
|
September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)
Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry
|
August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)
Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Page
of 1